Australian hearing‑implant manufacturer Cochlear Ltd. disclosed on Tuesday that it has been served with a shareholder class action in the Supreme Court of Victoria. The lawsuit alleges that the company misled investors about its fiscal 2026 underlying net profit forecast.
Profit forecast cut and market reaction
On April 22, Cochlear reduced its 2026 underlying net profit guidance to a range of A$290 million to A$330 million, citing weak trading conditions and uncertainty stemming from the ongoing Middle East conflict. The revision caused the company’s shares to plunge 40.7%.
Prior to the cut, Cochlear had indicated that profit was tracking toward the lower end of its previously stated range of A$435 million to A$460 million.
Details of the shareholder claim
The class action represents investors who purchased Cochlear shares between August 15, 2025 and April 21, 2026. The plaintiffs allege that the company’s statements about its profit outlook were misleading and that the subsequent forecast reduction caused significant losses for shareholders.
Cochlear has denied the allegations and said it will vigorously defend the proceedings. The company did not immediately respond to a Reuters request for further details about the claims.
Recent financial performance
In mid‑August, Cochlear reported an underlying net profit of A$322.4 million for 2026. At the time of reporting, the exchange rate was $1 = 1.4255 Australian dollars.
While the lawsuit adds a layer of uncertainty for investors, Cochlear’s management emphasizes its commitment to delivering innovative hearing solutions and maintaining a strong market position globally.
Original reporting: Appleton, WI News Feed (HLL/CB) — read the source article.
